Cargando…

Infection and Risk of Parkinson’s Disease

Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. En...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeyne, Richard J., Noyce, Alastair J., Byrne, Matthew, Savica, Rodolfo, Marras, Connie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414/
https://www.ncbi.nlm.nih.gov/pubmed/33361610
http://dx.doi.org/10.3233/JPD-202279
_version_ 1783669067820826624
author Smeyne, Richard J.
Noyce, Alastair J.
Byrne, Matthew
Savica, Rodolfo
Marras, Connie
author_facet Smeyne, Richard J.
Noyce, Alastair J.
Byrne, Matthew
Savica, Rodolfo
Marras, Connie
author_sort Smeyne, Richard J.
collection PubMed
description Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. Encephalitis caused by influenza has included parkinsonian features. Epidemiological evidence is most compelling for an association between PD and hepatitis C virus. Infection with Helicobacter pylori may be associated not only with PD risk but also response to levodopa. Rapidly evolving knowledge regarding the role of the microbiome also suggests a role of resident bacteria in PD risk. Biological plausibility for the role for infectious agents is supported by the known neurotropic effects of specific viruses, particular vulnerability of the substantia nigra and even the promotion of aggregation of alpha-synuclein. A common feature of implicated viruses appears to be production of high levels of cytokines and chemokines that can cross the blood-brain barrier leading to microglial activation and inflammation and ultimately neuronal cell death. Based on multiple avenues of evidence it appears likely that specific bacterial and particularly viral infections may increase vulnerability to PD. The implications of this for PD prevention requires attention and may be most relevant once preventive treatments for at-risk populations are developed.
format Online
Article
Text
id pubmed-7990414
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-79904142021-04-14 Infection and Risk of Parkinson’s Disease Smeyne, Richard J. Noyce, Alastair J. Byrne, Matthew Savica, Rodolfo Marras, Connie J Parkinsons Dis Review Parkinson’s disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. Encephalitis caused by influenza has included parkinsonian features. Epidemiological evidence is most compelling for an association between PD and hepatitis C virus. Infection with Helicobacter pylori may be associated not only with PD risk but also response to levodopa. Rapidly evolving knowledge regarding the role of the microbiome also suggests a role of resident bacteria in PD risk. Biological plausibility for the role for infectious agents is supported by the known neurotropic effects of specific viruses, particular vulnerability of the substantia nigra and even the promotion of aggregation of alpha-synuclein. A common feature of implicated viruses appears to be production of high levels of cytokines and chemokines that can cross the blood-brain barrier leading to microglial activation and inflammation and ultimately neuronal cell death. Based on multiple avenues of evidence it appears likely that specific bacterial and particularly viral infections may increase vulnerability to PD. The implications of this for PD prevention requires attention and may be most relevant once preventive treatments for at-risk populations are developed. IOS Press 2021-02-02 /pmc/articles/PMC7990414/ /pubmed/33361610 http://dx.doi.org/10.3233/JPD-202279 Text en © 2021 – IOS Press. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Smeyne, Richard J.
Noyce, Alastair J.
Byrne, Matthew
Savica, Rodolfo
Marras, Connie
Infection and Risk of Parkinson’s Disease
title Infection and Risk of Parkinson’s Disease
title_full Infection and Risk of Parkinson’s Disease
title_fullStr Infection and Risk of Parkinson’s Disease
title_full_unstemmed Infection and Risk of Parkinson’s Disease
title_short Infection and Risk of Parkinson’s Disease
title_sort infection and risk of parkinson’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414/
https://www.ncbi.nlm.nih.gov/pubmed/33361610
http://dx.doi.org/10.3233/JPD-202279
work_keys_str_mv AT smeynerichardj infectionandriskofparkinsonsdisease
AT noycealastairj infectionandriskofparkinsonsdisease
AT byrnematthew infectionandriskofparkinsonsdisease
AT savicarodolfo infectionandriskofparkinsonsdisease
AT marrasconnie infectionandriskofparkinsonsdisease